Simpler Grants.gov #HT942526SCIRPTRA

Translational Research Grants for Spinal Cord Injury (FY26)

The Department of the Army, through the U.S. Army Medical Research Acquisition Activity (USAMRAA) and the Defense Health Agency's Congressionally Directed Medical Research Programs (CDMRP), is soliciting applications for the FY26 Spinal Cord Injury Research Program (SCIRP) Translational Research Award (TRA). - Purpose: Support translational research to accelerate promising spinal cord injury (SCI) research into clinical applications - Funding: Approximately $8.32 million total, supporting about 4 awards - Single Principal Investigator (PI) awards capped at $2.0 million - Early-Career Partnership Option awards capped at $2.16 million - Period of Performance: Maximum of 3 years per award - Key Requirements: - Mandatory inclusion of at least one SCI community partner for consultation throughout the project - Early-Career Partnership Option requires at least one early-career investigator if two PIs are proposed - Projects must address one of four priority areas: acute injury intervention, secondary health effects, psychosocial well-being, or rehabilitation and regeneration - Emphasis on translational potential, community collaboration, and relevance to military health - No specific OEMs, vendors, or product/equipment procurements are identified, as this is a research grant opportunity

Description

The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Translational Research Award (TRA) supports translational research aimed at accelerating the movement of promising ideas in spinal cord injury (SCI) research into clinical applications. This funding opportunity includes an Early-Career Partnership Option allowing two principal investigators, with at least one being an early-career investigator. Applications must include at least one SCI community partner to provide advice and consultation throughout the research project. The program expects to fund approximately 4 awards with a total funding amount of $8,320,000 and a maximum period of performance of 3 years.

View original listing